期刊文献+

两种分离方法培养成体大鼠骨髓间充质干细胞的比较分析 被引量:1

Comparative Analysis of Adherent Culture Method and Density Gradient Centrifugation in Culturing Adult Rat Bone Marrow Mesenchymal Stem Cells
下载PDF
导出
摘要 目的比较分析目前较简单易行的贴壁培养法和密度梯度离心法培养大鼠骨髓间充质干细胞(MSCs)的效果.方法用贴壁培养法和密度梯度离心法分别培养大鼠MSCs,流式细胞仪检测MSCs的表面标记物.结果贴壁培养法培养的原代细胞较密度梯度离心法培养的原代细胞生长快,但传代细胞这一差异不明显;而密度梯度离心法培养的原代细胞较贴壁培养法培养的原代细胞形态一致,随着传代的增加,贴壁培养法培养的细胞形态逐步趋于一致.流式细胞仪检测示:贴壁培养法培养的细胞:CD29(99.8%)、CD90(99.6%)、CD34(3.01%);密度梯度离心法培养的细胞:CD29(100%)、CD90(97.1%)、CD34(0.89%).结论用贴壁培养法和密度梯度离心法都可以得到纯度较高的MSCs,两种培养方法的效果无明显差异. Objective To compare and analyze the results of culturing mesenchymal stem cells(MSCs) by adherent culture method and density gradient centrifugation.Methods Rat bone marrow MSCs were isolated and cultured by adherent culture method and density gradient centrifugation separately.Flow cytometry was used to detect their surface markers.Results The primary cultured cells by adherent culture method grew faster than those cells by density gradient centrifugation,but the difference was not obvious in the passage cells.The shape of primary cultured cells by density gradient centrifugation was similar to these cells by adherent culture method,but with the passaging,cultured cells in adherent culture gradually form into cell line.The tests of flow cytometry showed CD29(99.8%),CD90(99.6%),and CD34(3.01%)in these cells by adherent culture method.And in these cells by density gradient centrifugation,the results showed CD29(100%),CD90(97.1%),and CD34(0.89%).Conclusion Rat bone marrow MSCs can be obtained by adherent culture method and density gradient centrifugation,and there is no significant difference between the two culture ways.
出处 《昆明医学院学报》 2010年第11期53-57,共5页 Journal of Kunming Medical College
关键词 间充质干细胞 细胞培养 表面标记物 Mesenchymal stem cells cell culture Surface markers
  • 相关文献

参考文献13

  • 1GANG E J,JEONG J A,HAN S,et al. In vitro endothelial potential of human UC blood-derived mesenchymal stem cells[ J ]. Cytotherapy, 2006,8 (3) : 215 - 227.
  • 2SHIMOMURA T, YOSHIDA Y, SAKABE T, et al. Hepatic differentiation of human bone marrow-derived UE7T-13 cells:effects of cytokines and CCN family gene expression [J]. Hepatol Res,2007,37 (12): 1068 - 1079.
  • 3YOSHIDA Y,SHIMOMURA T,SAKABE T,et al. A role of Wnt/beta-catenin signals in hepatic fate specification of human umbilical cord blood-derived mesenchymal stem cells[J]. Am J Physiol Gastrointest Liver Physiol,2007, 293(5 ) : 1089 - 1098.
  • 4董巧凤,贺韦东,尹哲,王迎雪,李丽珍,郭成山.骨髓间充质干细胞的体外扩增及其对T淋巴细胞产生IFN-γ和IL-10的影响[J].现代免疫学,2007,27(2):140-144. 被引量:17
  • 5邱丽燕,王金福.骨髓间充质干细胞的研究进展[J].生物工程学报,2003,19(2):136-140. 被引量:18
  • 6BONNET D.Biology of human bone marrow stem cells [ J ]. Clin Exp Med,2003,3(3 ): 140 - 149.
  • 7KUO T K, HUNG S P, CJIAMG C H, et al. Stem cell th - erapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells [J]. Gastroenterology, 2008,134(7) : 2111 - 2121.
  • 8YAN Y, X U W, QIAN H, et al. Mesenchymal stem cells from human umbilical cords ameliorate mouse hepatic injury in vivo[ J ]. Liver Int, 2009,29(3 )~: 356 - 365.
  • 9CHIEN C C, YEN B L, LEE F K, et al. In vitro differentiation of human placenta-derived muhipotent cells into hepatocytelike cells [J]. Stem Cells,2006,24 (7): 1759- 1768.
  • 10BANAS A,TERATANI T,YAMAMOTO Y,et al. IFATS collection:in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury [J]. Stem Cells,2008,26 (10): 2705 - 2712.

二级参考文献17

  • 1江小霞,张毅,李秀森,吴英,于晓妉,唐佩弦,毛宁.间充质干细胞对T淋巴细胞转化的影响[J].解放军医学杂志,2005,30(2):130-132. 被引量:10
  • 2陆晓茜,刘霆,孟文彤,朱焕玲,席亚明,刘咏梅.人骨髓间充质干细胞对T淋巴细胞的免疫调节作用[J].中国实验血液学杂志,2005,13(4):651-655. 被引量:15
  • 3Pittenger MF,Msckay AM,Beck SC,et al.Multilineage potential of adult human mesenchymal stem cells[J].Science,1999,284:143-147.
  • 4Robert JD,Annermarie BM.Mesenchymal stem cells:biology and potential clinical uses[J].Exp Hematol,2000,28:875-884.
  • 5Friedenstein AJ,Chailakhyan RK,Gerasimov UV.Bone marrow osteogenic stem cells:in vitro cultivation and transplantation in diffusion chambers[J].Cell Tissue Kinet,1987,20:263-272.
  • 6Miyashima S,Nagata N,Nakagawa T,et al.Prevention of lpr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bones (stromal cells) from MRL/lpr mice[J].J Immunol,1996,156:79-84.
  • 7Bartholomew A,Sturgeon C,Siatskas M,et al.Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo[J].Exp Hematol,2002,30:42-48.
  • 8Aggarwal S,Pittenger MF.Human mesenchymal stem cells modulate allogeneic immune cell responses[J].Blood,2005,105:1815-1822.
  • 9Andrea B,Marisa V,Marina P,et al.T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia[J].Exp Hematol,2005,33:819-827.
  • 10Rasmusson I,Ringden O,Sundlberg B,et al.Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms[J].Exp Cell Res,2005,305:33-41.

共引文献42

同被引文献17

  • 1桂莉,范文辉,李露斯,陈康宁,史树贵.大鼠骨髓间充质干细胞生物学特性及分化潜能研究[J].重庆医学,2004,33(10):1519-1521. 被引量:1
  • 2Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells [J]. Science, 1999, 284(5411): 143-147.
  • 3Zhang L, Chan C. Isolation and enrichment of rat mesenchymal stem cells (MSCs) and separation of single-colony derived MSCs [J]. J Vis Exp, 2010, (37): 1852.
  • 4Sensebe L, Bourin P. Mesenchymal stem cells for therapeutic purposes [J]. Transplantation, 2009, 87(9 Suppl): 49-53.
  • 5Ho AD, Wagner W, Franke W. Heterogeneity of mesenchymal stromal cell preparations [J]. Cytotherapy, 2008, 10(4): 320-330.
  • 6De Ugarte DA, Alfonso Z, Zuk PA, et al. Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow [J]. Immunol Lett, 2003, 89 (2-3): 267-270.
  • 7Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses [J]. Exp Hematol, 2000, 28(8): 875-884.
  • 8Friedenstein A J, Petrakova KV, Kurolesova AI, et al. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues [J]. Transplantation, 1968, 6(2):230-247.
  • 9Kashiwakrura Y, Katob Y, Tamayose K, et al. Isolation of bone marrow stromal cell-derived smooth muscle cells by a human SM22alpha promoter: in vitro differentiation of putative smooth muscle progenitor cells of bone marrow[J].Circulation, 2003, 107 (16): 2078-2081.
  • 10Pountos I, Corscadden D, Emery P, et al. Mesenchymal stem cell tissue engineering: techniques for isolation, expansion and application [J]. Injury, 2007, 38(S4): S23-33.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部